Y-Intercept (HK)’s Arcosa ACA Stock Holding History

Y-Intercept (HK)’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,471	Closed	-$475K	–	1503
2025 Q4	$475K	Sell	4,471 -17,566	-80%	-$1.77M	0.01%	1250
2025 Q3	$2.07M	Buy	22,037 +9,023	+69%	+$839K	0.05%	584
2025 Q2	$1.13M	Buy	+13,014	New	+$1.09M	0.03%	879
2022 Q3	–	Sell	-6,461	Closed	-$300K	–	929
2022 Q2	$300K	Buy	+6,461	New	+$339K	0.04%	583

Other funds holding ACA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Y-Intercept (HK)'s ACA Position: Q1 2026 in Review

Y-Intercept (HK) sold out of Arcosa (ACA) in Q1 2026, closing a stake of 4,471 shares — an estimated $475K sold.

Y-Intercept (HK) first reported a position in ACA in Q2 2022 and held it in 4 quarters. The position peaked at $2.07M in Q3 2025. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

Y-Intercept (HK) reported no remaining Arcosa position as of Q1 2026 after selling out during the quarter.
Y-Intercept (HK) sold 4,471 Arcosa shares in Q1 2026, an estimated $475K.
Y-Intercept (HK) first reported a position in Arcosa in Q2 2022 and held it in 4 quarters.
Y-Intercept (HK)'s Arcosa position peaked at $2.07M in Q3 2025.
372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.